Honest, Unfiltered Assistance
Voranigo: Information on price, potential adverse effects, applications, and dosage details
Voranigo is a branded oral tablet primarily utilized for treating certain brain tumors, specifically Grade 2 astrocytomas and oligodendrogliomas in adults and children aged 12 years and up. These tumors are a specific type of brain tumor called gliomas. Voranigo is prescribed in specific scenarios as a targeted cancer therapy. For more details, check out the "Voranigo Uses" section.
Drug Basics
- Drug Class: Voranigo falls under the category of isocitrate dehydrogenase-1 and isocitrate dehydrogenase-2 inhibitors, classifying it as a type of targeted cancer therapy.
- Generic Form: At present, Voranigo is exclusively offered as a brand-name medication and doesn't have a generic version available.
- Prescription: Yes, a doctor's prescription is required to obtain Voranigo.
- Controlled Substance: No, Voranigo is not classified as a controlled substance.
Voranigo Cost and Coupons
Drug costs can vary based on factors such as insurance, location, and pharmacy. To learn more about financial and insurance assistance, check out the ServierONE program for Voranigo. You can get in touch with them at 800-813-5905 or by visiting their website.
less than 40 kg (about 88 pounds [lb])
Side Effects
20 mg once per day
Like any medication, Voranigo can induce mild or severe side effects. Here's a partial list of possible mild side effects:
- fatigue
- headache
- nausea
- diarrhea
- constipation
- reduced appetite
- muscle or joint pain or stiffness
- COVID-19
- decreased white blood cell count
- increased liver enzymes
40 kg or more
If these side effects become more severe or don't disappear, consult your doctor or pharmacist.
40 mg once per day
In the event of serious side effects, contact your doctor immediately. Some severe side effects and their symptoms are:
- liver problems with symptoms like:
- pain in the upper right abdomen
- loss of appetite
- severe tiredness or weakness
- dark urine
- jaundice
- seizures with symptoms like:
- staring into space
- rapid blinking
- sudden stiffening of arms/body
- jerking body movements
- loss of consciousness
In case of an allergic reaction, seek medical help immediately. For more information on the possible side effects of Voranigo, talk with your doctor or pharmacist.
Voranigo Uses
• ciprofloxacin (Cipro)• cyclosporine (Neoral, others)• fluvoxamine (Luvox)• phenytoin (Dilantin, Phenytek)• rifampin (Rifadin, Rimatane)• hormonal forms of birth control, such as the combined pill, minipill, or patch
Voranigo is FDA-approved to treat specific brain tumors in adults and children aged 12 years and older. It's used for Grade 2 astrocytomas and oligodendrogliomas with IDH1 or IDH2 mutations. For further details, see the "Voranigo Uses" section.
Voranigo for Children
Voranigo has only been studied in children aged 12 and older, and its safety and effectiveness in younger children are unproven.
Things to Consider
- Pregnancy: Voranigo can cause harm to the fetus and should generally be avoided during pregnancy. Discuss birth control options with your doctor before starting Voranigo treatment.
- Fertility: Voranigo may reduce fertility in both males and females. If you plan to have children in the future, talk to your doctor about your options before starting Voranigo treatment.
- Breastfeeding: Voranigo should not be taken while breastfeeding. If you are currently breastfeeding or planning to do so, discuss it with your doctor.
About Voranigo
Voranigo is designed to slow the growth of specific brain tumors by blocking the action of abnormal IDH1 and IDH2 enzymes. These enzymes contribute to the tumor's growth when they are mutated.
For more information about Voranigo, its interactions, alternatives, or other aspects, consult your healthcare provider.
[1]https://www.medicinenet.com/voranigo/alternate/[2]https://www.drugs.com/voranigo.html
- Voranigo is designed to slow the growth of specific brain tumors, like astrocytomas and oligodendrogliomas, by blocking the action of abnormal IDH1 and IDH2 enzymes, which are involved in cancer growth when mutated.
- Voranigo, a brand-name medication, falls under the category of isocitrate dehydrogenase-1 and isocitrate dehydrogenase-2 inhibitors, making it a type of targeted cancer therapy.
- Although Voranigo can be effective in treating certain brain tumors, it may induce mild to severe side effects, such as fatigue, headache, nausea, diarrhea, constipation, reduced appetite, muscle or joint pain or stiffness, liver problems, seizures, or allergic reactions.
- In the field of science and medical-conditions, Voranigo plays a role in addressing health challenges, particularly in oncology and neurological domains related to brain disorders, including brain tumors and other brain-related disorders.
- Cancer patients undergoing Voranigo treatment should be aware that certain medications can interact with the drug, such as ciprofloxacin (Cipro), cyclosporine, fluvoxamine (Luvox), phenytoin (Dilantin, Phenytek), rifampin (Rifadin, Rimatane), or hormonal forms of birth control.
